Lipocine Inc (LPCN)
4.55
+0.11
(+2.48%)
USD |
NASDAQ |
Apr 25, 16:00
4.57
+0.02
(+0.44%)
After-Hours: 20:00
Lipocine Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -2.515M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -2.398M |
| March 31, 2022 | |
| December 31, 2021 | 13.83M |
| September 30, 2021 | -2.312M |
| June 30, 2021 | -1.465M |
| March 31, 2021 | |
| December 31, 2020 | -2.480M |
| September 30, 2020 | -2.488M |
| June 30, 2020 | -2.269M |
| March 31, 2020 | |
| December 31, 2019 | -1.841M |
| September 30, 2019 | -1.548M |
| June 30, 2019 | -1.964M |
| March 31, 2019 | -1.950M |
| December 31, 2018 | -2.182M |
| September 30, 2018 | -1.423M |
| June 30, 2018 | -1.482M |
| March 31, 2018 | -0.9495M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.767M |
| September 30, 2017 | -2.046M |
| June 30, 2017 | -4.107M |
| March 31, 2017 | -3.084M |
| December 31, 2016 | -1.328M |
| September 30, 2016 | -1.507M |
| June 30, 2016 | -2.568M |
| March 31, 2016 | -2.673M |
| December 31, 2015 | -2.766M |
| September 30, 2015 | -4.734M |
| June 30, 2015 | -3.162M |
| March 31, 2015 | -1.919M |
| December 31, 2014 | -2.890M |
| September 30, 2014 | -3.246M |
| June 30, 2014 | -5.974M |
| March 31, 2014 | -3.369M |
| December 31, 2013 | -2.465M |
| September 30, 2013 | -1.569M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | -0.5478M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-2.515M
Minimum
Jun 2023
13.83M
Maximum
Dec 2021
-0.677M
Average
-2.269M
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | -- |
| Eliem Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.815M |
| Palatin Technologies Inc | 1.936M |
| iBio Inc | -- |